Drugmakers Should Revisit Marketing Contracts In Light of New HHS Rule

Drug Industry Daily
A A
Drugmakers should review the marketing contracts they have in place with pharmacies or other third parties to ensure the information they send to patients complies with new HHS limitations.

To View This Article:

Login

Subscribe To Drug Industry Daily